Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: Two cases with marked alleviation of clinical symptoms
✍ Scribed by Toshihide Suzuki; Yuichi Sato; Shinichiro Niizuma; Toshio Kushiro; Shigemasa Tani; Kazutoshi Ishikawa; Nagao Kajiwara; Katsuo Kanmatsuse; Hironori Ikeda; Motoichirou Takahashi; Shunichi Kojima
- Book ID
- 102296353
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 214 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have recognized marked effectiveness for intermittent claudication with low‐density lipoprotein (LDL) apheresis in two cases of arteriosclerosis obliterans (ASO). The Case 1 was a 73‐year‐old man with intermittent claudication of both lower extremities (Fontaine class II), digital subtraction angiography (DSA) revealed complete obstruction of the left common iliac artery, formation of a collateral to the peripheral portion of the left common iliac artery, and diffuse stenosis of the peripheral portion of the right common iliac artery. Ten sessions of LDL apheresis (LDL‐A) improved the walking distance from 100 m before to 600 m after LDL‐A treatment. The Case 2 was a 61‐year‐old man with intermittent claudication of the left lower extremity (walking distance: 200 m) began at 59 years. DSA revealed diffuse stenosis of the peripheral portion of the left popliteal artery. Ten sessions of LDL‐A improved the walking distance from 200 m before to 800 m after LDL‐A. At one month after the end of LDL‐A treatment, DSA revealed formation of collateral to the peripheral portion of the left popliteal artery. Our findings suggest that LDL‐A combined with drug treatment is safe and useful for the treatment of ASO, especially walking distance improved with short term treatment. J. Clin. Apheresis. 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES